IGF2 and neoplasm: Normally, circulating IGFs are bound to insulin growth factor-binding proteins (IGFBPs), which regulate their effects and reduce their availability [3]; however, studies have found that IGF-II that is produced by tumor cells is a partially processed IGF-II, referred to as big IGF-II due to incomplete glycosylation of precursor molecules [3].